BackShinpoong Pharmaceutical ,Ltd Overview
Shinpoong Pharmaceutical Co.,Ltd

Shinpoong Pharmaceutical ,Ltd Return on Equity

Latest ROE for Shinpoong Pharmaceutical ,Ltd: -0.29% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

-0.29%

Return on Equity

-0.29%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Shinpoong Pharmaceutical ,Ltd (019175.KS) FAQ

The latest ROE for 019175.KS is -0.29%. That is below the sector sector average of 11.3%. Investors often review this figure alongside Shinpoong Pharmaceutical ,Ltd's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, 019175.KS currently prints -0.29% for ROE, while the sector average sits near 11.3%. That is roughly 102.6% below the sector mean. Large gaps often invite a closer look at Shinpoong Pharmaceutical ,Ltd's growth, margins, and balance sheet.

Return on Equity shows how effectively Shinpoong Pharmaceutical ,Ltd converts resources into returns. At -0.29%, 019175.KS may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting 019175.KS's ROE (-0.29%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.